83 related articles for article (PubMed ID: 11189517)
1. [Detection of TCR gamma gene in acute lymphoblastic leukemia after remission and its clinical significance].
Liu L; Sun J; Yin H
Zhonghua Xue Ye Xue Za Zhi; 1998 Jul; 19(7):353-5. PubMed ID: 11189517
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group.
Cavé H; van der Werff ten Bosch J; Suciu S; Guidal C; Waterkeyn C; Otten J; Bakkus M; Thielemans K; Grandchamp B; Vilmer E
N Engl J Med; 1998 Aug; 339(9):591-8. PubMed ID: 9718378
[TBL] [Abstract][Full Text] [Related]
3. PCR detection of clonal IgH and TCR gene rearrangements at the end of induction as a non-remission criterion in children with ALL: comparison with standard morphologic analysis and risk group classification.
Scrideli CA; Queiroz RG; Bernardes JE; Valera ET; Tone LG
Med Pediatr Oncol; 2003 Jul; 41(1):10-6. PubMed ID: 12764736
[TBL] [Abstract][Full Text] [Related]
4. Residual disease detection in multiple follow-up samples in children with acute lymphoblastic leukemia.
Kitchingman GR
Leukemia; 1994 Mar; 8(3):395-401. PubMed ID: 8127144
[TBL] [Abstract][Full Text] [Related]
5. Minimal residual disease monitoring in adult T-cell acute lymphoblastic leukemia: a molecular based approach using T-cell receptor G and D gene rearrangements.
Gameiro P; Mortuza FY; Hoffbrand AV; Foroni L
Haematologica; 2002 Nov; 87(11):1126-34. PubMed ID: 12414341
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of detection of monoclonality in remission marrow in acute lymphoblastic leukemia in childhood. Australian and New Zealand Children's Cancer Study Group.
Brisco MJ; Condon J; Hughes E; Neoh SH; Nicholson I; Sykes PJ; Tauro G; Ekert H; Waters K; Toogood I
Leukemia; 1993 Oct; 7(10):1514-20. PubMed ID: 8412313
[TBL] [Abstract][Full Text] [Related]
7. [Dynamic analysis of junctional sequences of T cell receptor (TCR) delta and gamma gene rearrangement in childhood with acute lymphoblastic leukemia].
Lu J; Gu R; Lei K; Wang X; Sun L; Pang X; Li X; Dong Z
Zhonghua Xue Ye Xue Za Zhi; 2000 Jun; 21(6):301-4. PubMed ID: 11876997
[TBL] [Abstract][Full Text] [Related]
8. Analysis of clonality of lymphocytic leukemia and lymphoma by T-cell receptor gene rearrangement.
Zhu P; Wu S; Xue H; Lu Y; Wang L; Zhang Y; Yu J
Chin Med J (Engl); 1997 Aug; 110(8):607-11. PubMed ID: 9594264
[TBL] [Abstract][Full Text] [Related]
9. Minimal residual disease (MRD) monitoring using rearrangement of T-cell receptor and immunoglobulin H gene in the treatment of adult acute lymphoblastic leukemia patients.
Toubai T; Tanaka J; Ota S; Fukuhara T; Hashino S; Kondo T; Kasai M; Kakinoki Y; Masauzi N; Morioka M; Kawamura T; Iwasaki H; Asaka M; Imamura M
Am J Hematol; 2005 Nov; 80(3):181-7. PubMed ID: 16247752
[TBL] [Abstract][Full Text] [Related]
10. [Establishment of a real time quantitative-PCR assay for detection of TCR VgammaI-Jgamma gene rearrangement in acute lymphoblastic leukemia patients].
Jiang XG; Xu B; Xu WJ; Li B
Zhonghua Xue Ye Xue Za Zhi; 2004 Jul; 25(7):425-8. PubMed ID: 15355697
[TBL] [Abstract][Full Text] [Related]
11. Molecular detection of minimal residual disease is associated with early relapse in adult acute lymphoblastic leukemia.
Specchia G; Liso A; Pannunzio A; Albano F; Mestice A; Pastore D; Liso V
Haematologica; 2004 Oct; 89(10):1271-3. PubMed ID: 15477219
[TBL] [Abstract][Full Text] [Related]
12. Detection of minimal residual disease in leukemia using polymerase chain reaction and restriction analysis.
Wu N; Lu S; Zhu P; Liu L; Peng Y
Chin Med J (Engl); 1997 Jan; 110(1):73-7. PubMed ID: 9594329
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of T cell receptor V gamma I-J gamma gene rearrangement in elderly patients with acute leukemia].
Xu B; Wei YQ; Zhao YZ; Zhou SY; Meng FY
Di Yi Jun Yi Da Xue Xue Bao; 2003 Dec; 23(12):1266-9. PubMed ID: 14678886
[TBL] [Abstract][Full Text] [Related]
14. Minimal residual disease in childhood acute lymphoblastic leukemia: analysis of patients in continuous complete remission or with consecutive relapse.
Biondi A; Yokota S; Hansen-Hagge TE; Rossi V; Giudici G; Maglia O; Basso G; Tell C; Masera G; Bartram CR
Leukemia; 1992 Apr; 6(4):282-8. PubMed ID: 1316978
[TBL] [Abstract][Full Text] [Related]
15. Immunogenotype changes prevail in relapses of young children with TEL-AML1-positive acute lymphoblastic leukemia and derive mainly from clonal selection.
Panzer-Grümayer ER; Cazzaniga G; van der Velden VH; del Giudice L; Peham M; Mann G; Eckert C; Schrauder A; Germano G; Harbott J; Basso G; Biondi A; van Dongen JJ; Gadner H; Haas OA
Clin Cancer Res; 2005 Nov; 11(21):7720-7. PubMed ID: 16278392
[TBL] [Abstract][Full Text] [Related]
16. T-cell receptor gamma and delta gene rearrangements and junctional region characteristics in south Indian patients with T-cell acute lymphoblastic leukemia.
Sudhakar N; Nancy NK; Rajalekshmy KR; Ramanan G; Rajkumar T
Am J Hematol; 2007 Mar; 82(3):215-21. PubMed ID: 17133429
[TBL] [Abstract][Full Text] [Related]
17. [Monitoring minimal residual disease in pediatric patients with acute lymphoblastic leukemia].
Zuna J; Hrusák O; Kalinová M; Muzíková K; Zörnerová T; Starý J; Trka J
Vnitr Lek; 2000 Aug; 46(8):465-9. PubMed ID: 11048511
[TBL] [Abstract][Full Text] [Related]
18. [Preliminary results of the use of MRD test among children with acute lymphoblastic leukaemia].
Raciborska A; Wypych A; Rokicka-Milewska R; Siedlecki JA; Kulik J
Przegl Lek; 2004; 61 Suppl 2():62-6. PubMed ID: 15686049
[TBL] [Abstract][Full Text] [Related]
19. Expression of CD58 in normal, regenerating and leukemic bone marrow B cells: implications for the detection of minimal residual disease in acute lymphocytic leukemia.
Veltroni M; De Zen L; Sanzari MC; Maglia O; Dworzak MN; Ratei R; Biondi A; Basso G; Gaipa G;
Haematologica; 2003 Nov; 88(11):1245-52. PubMed ID: 14607753
[TBL] [Abstract][Full Text] [Related]
20. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
